Consolidated results for the second quarter of fiscal year ending September 2026 show net sales of approximately 25,600 million yen, operating profit of approximately 2,800 million yen, and net income of approximately 1,900 million yen, all increasing YoY. Segments such as the Medical Care Facility Business and Comprehensive Medical Support Business performed well.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7071","jir_company_name":"Ambis Holdings Co., Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2605","jir_publication_date":"2026-05-14","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/05\/7071-20260514-02.pdf","jir_short_summary":"Consolidated results for the second quarter of fiscal year ending September 2026 show net sales of approximately 25,600 million yen, operating profit of approximately 2,800 million yen, and net income of approximately 1,900 million yen, all increasing YoY. Segments such as the Medical Care Facility Business and Comprehensive Medical Support Business performed well.","jir_summary":"### Overview of Results\nAmbis Holdings Co., Ltd. recorded net sales of approximately 25,600 million yen, operating profit of approximately 2,800 million yen, and net income of approximately 1,900 million yen for the second quarter of fiscal year ending September 2026, significantly increasing compared to the same period last year. The Medical Care Facility Business and the Comprehensive Medical Support Business performed well; notably, the Medical Care Facility Business's net sales increased by 6.1% to approximately 25,033 million yen, with profits also growing substantially. The company is recovering from the impact of the COVID-19 pandemic and plans to continue active business expansion.\n\n### Outlook and Impact on Shareholders\nFull-year projections estimate net sales of approximately 51,700 million yen, operating profit of about 3,800 million yen, and net income of roughly 2,700 million yen, reflecting expected increases in both sales and profits compared to the previous period. The company plans to enhance profitability through expansion of healthcare support services and new business development. Shareholder return strategies such as increased dividends and share buybacks are also being considered, ensuring continued attractive corporate management for investors.","jir_financial_highlights":"Net Sales: 25,600 million yen (YoY +7.5%)\nOperating Profit: 2,804 million yen (YoY +25.1%)\nNet Income: 1,896 million yen (YoY +29.5%)","jir_category":"","jir_hashtags":"#AmbisHoldings, #FinancialSummary, #JapaneseStocks","jir_key_figures":"Net Sales: 25,600 million yen (YoY +7.5%)\nOperating Profit: 2,804 million yen (YoY +25.1%)\nNet Income: 1,896 million yen (YoY +29.5%)","jir_meta_title":"\u3010Ambis Holdings\u3011FY2026 September Second Quarter Results | Revenue Growth and Profit Increase","jir_meta_description":"Overview of Ambis Holdings' second quarter results for FY2026 ending September. Net sales of approximately 25,600 million yen, profit growth, and future outlook explained in detail.","jir_og_title":"\u3010Ambis Holdings\u3011FY2026 Second Quarter Results | Revenue Growth and Profit Increase","jir_og_description":"Detailed analysis of Ambis Holdings' latest financial results and future business outlook. Full of information useful for investment decisions.","jir_og_image_url":"\/assets\/og\/company-financial_summary.jpg","jir_chart_data_collection":"[{\"jir_chart_id\": \"revenue_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Revenue Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"October 2024\\\",\\\"March 2025\\\",\\\"September 2025\\\",\\\"March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Sales\\\",\\\"data\\\":[23592,25033,25600,25603],\\\"borderColor\\\":\\\"#3e95cd\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true}}\"}, {\"jir_chart_id\": \"operating_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Operating Profit Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"October 2024\\\",\\\"March 2025\\\",\\\"September 2025\\\",\\\"March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Operating Profit\\\",\\\"data\\\":[3812,3743,2804,2789],\\\"borderColor\\\":\\\"#8e5ea2\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true}}\"}, {\"jir_chart_id\": \"net_profit_trend\", \"jir_chart_type\": \"line\", \"jir_chart_title\": \"Net Income Trend\", \"jir_chart_json_data\": \"{\\\"type\\\":\\\"line\\\",\\\"data\\\":{\\\"labels\\\":[\\\"October 2024\\\",\\\"March 2025\\\",\\\"September 2025\\\",\\\"March 2026\\\"],\\\"datasets\\\":[{\\\"label\\\":\\\"Net Income\\\",\\\"data\\\":[2688,2688,1896,1896],\\\"borderColor\\\":\\\"#3cba54\\\",\\\"fill\\\":false}]},\\\"options\\\":{\\\"responsive\\\":true}}\"}]","ir_related_company":17546,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-51692","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n